News

Cure Alzheimer’s Fund Receives Highest Rating from Charity Navigator

Posted: Feb. 4, 2013

Cure Alzheimer’s Fund has been awarded the highest rating for sound fiscal management and commitment to accountability and transparency by Charity Navigator, the country’s largest and most-utilized independent evaluator of charities.

Drs. Marc Tessier-Lavigne and Robert Malenka Join Scientific Advisory Board

Posted: Jan. 29, 2013

Cure Alzheimer's Fund (CAF) welcomes two new Scientific Advisory Board (SAB) members: Marc Tessier-Lavigne, Ph.D., president of The Rockefeller University, and former CAF Research Consortium member Robert C. Malenka, M.D., Ph.D., of Stanford University.

Featured Researcher: Giuseppina Tesco, M.D., Ph.D.

Posted: Jan. 23, 2013

Meet Dr. Giuseppina Tesco, Cure Alzheimer’s Funded researcher, and assistant professor of neuroscience, Alzheimer’s Disease Research Laboratory, Department of Neuroscience, Tufts University School of Medicine.

Early Days

Can Venture Capital Help Cure Alzheimer's Disease?

Posted: Dec. 13, 2012

A Pittsburgh philanthropist and retired Mellon exec thinks so. In 1988, Jeffrey L. Morby left American Express to join the management team tapped to rescue the nearly bankrupt Mellon Bank. After helping turn Mellon around, he retired at 59, but Morby has hardly been wiling away the time.

Calendars for a Cause

Posted: Dec. 12, 2012

When Maggie Campbell’s mother-in-law, Nancy Drapeau, was diagnosed with early-onset Alzheimer’s disease last summer at age 59, Campbell decided she wanted to do something to help. Originally from Omaha, Neb., Campbell is a bookbinder and letterpress printer in Brooklyn, N.Y.

Letter from the Chairs

Posted: Dec. 5, 2012

From our 2011 Annual Report.

 

Dear Friends,

On behalf of the Board of Directors and the Research Consortium, we want to thank all the donors, researchers and academic institutional partners supporting Cure Alzheimer’s Fund research for your help in making 2011 such a successful science year. Guided by leading scientists in the field, Cure Alzheimer’s Fund-supported research continues to make breakthrough progress toward our goal of eradicating Alzheimer’s disease.

TREM2: New candidate gene for AD

Posted: Nov. 15, 2012

Rudy Tanzi, Chair, Cure Alzheimer's Fund Research Consortium comments here on the AP article appearing on this topic today:

The Roadmap to Therapies 2012

Posted: Nov. 14, 2012

Alzheimer’s is the sixth leading cause of death in the United States, but its most devastating effects can’t be counted. The disease steals away memories; it turns loved ones into strangers; it makes home unfamiliar and takes away all the things that define an individual. And, until recently, there’s been little hope of stopping its progress.

Cure Alzheimer’s Fund was founded to support cutting-edge, high-potential research to help the Alzheimer’s research community get on a smarter, faster trajectory toward a cure.

Origins of Alzheimer's Increasingly Clear

Posted: Nov. 11, 2012

Consensus among Alzheimer’s researchers about the origins of the disease is growing. Most, including members of Cure Alzheimer’s Fund Research Consortium, agree that a combination of factors, beginning with the excessive build-up of the peptide Abeta42  triggering  the development of tau tangles, nerve cell death, and inflammation are all required for Alzheimer’s pathology.